EP 3 071 219 B1 relates to methods and pharmaceutical compositions for treating or preventing antibody-mediated rejection in organ transplant patients using a C1-esterase inhibitor.
Brief outline of the case
After having decided that the MR and AR1-3 had problems under Art 123(2), the OD decided maintenance according to AR4.